Clinical Trials Browser

Phase 2 × Carcinoma, Non-Small-Cell Lung × Imiquimod × Clear all

NCT01909752 2017-07-06

Combination Vaccine Immunotherapy (DRibbles) for Patients With Definitively-Treated Stage III Non-small Cell Lung Cancer

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms